Comparative efficacy and safety of Chinese patent medicines as adjunctive therapies for glycolipid regulation in metabolic syndrome: A network meta-analysis
{{output}}
Background and purpose: Effective management of glycolipid metabolism is key to reducing the risk of cardiovascular disease in patients with metabolic syndrome (MetS). Chinese patent medicines (CPMs), a type of standardized herba... ...
